Covered recipient · General Payments record
SAMUEL A TWEDT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$2,537.17
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $652.66 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $145.64 | 3 |
| ABBVIE INC. | $144.85 | 10 |
| Novo Nordisk AS | $100.63 | 5 |
| Lilly USA, LLC | $70.04 | 4 |
| PFIZER INC. | $68.70 | 3 |
| Amgen Inc. | $28.59 | 2 |
| Exact Sciences Corporation | $22.47 | 1 |
| Phathom Pharmaceuticals, Inc. | $22.36 | 1 |
| Electromed, Inc. | $20.41 | 1 |
| Astellas Pharma US Inc | $14.74 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.74 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255677 | CMS |
| ABBVIE INC. | $11.02 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255679 | CMS |
| ABBVIE INC. | $12.37 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255681 | CMS |
| ABBVIE INC. | $6.73 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255683 | CMS |
| ABBVIE INC. | $14.85 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255685 | CMS |
| ABBVIE INC. | $15.73 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255687 | CMS |
| ABBVIE INC. | $12.26 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255689 | CMS |
| ABBVIE INC. | $23.17 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255691 | CMS |
| ABBVIE INC. | $13.69 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255693 | CMS |
| ABBVIE INC. | $30.29 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255695 | CMS |
| Amgen Inc. | $15.19 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117705876 | CMS |
| Amgen Inc. | $13.40 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117705878 | CMS |
| Astellas Pharma US Inc | $14.74 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139333664 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.11 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104368963 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.71 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105826627 | CMS |
| AstraZeneca Pharmaceuticals LP | $8.82 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104560602 | CMS |
| Electromed, Inc. | $20.41 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137915257 | CMS |
| Exact Sciences Corporation | $22.47 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114936915 | CMS |
| Kowa Pharmaceuticals America, Inc. | $14.23 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113471221 | CMS |
| Lilly USA, LLC | $18.46 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135387035 | CMS |
| Lilly USA, LLC | $18.46 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135387037 | CMS |
| Lilly USA, LLC | $14.27 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135413855 | CMS |
| Lilly USA, LLC | $18.85 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135342445 | CMS |
| Novo Nordisk Inc | $16.15 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096829625 | CMS |
| Novo Nordisk Inc | $22.56 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097292600 | CMS |
| Novo Nordisk Inc | $22.27 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097152484 | CMS |
| Novo Nordisk Inc | $19.58 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096622164 | CMS |
| Novo Nordisk Inc | $20.07 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096952811 | CMS |
| PFIZER INC. | $15.52 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131799793 | CMS |
| PFIZER INC. | $34.44 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131817822 | CMS |
| PFIZER INC. | $18.74 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131796062 | CMS |
| Phathom Pharmaceuticals, Inc. | $22.36 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151134890 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.